Welcome to our dedicated page for Siriuspoint SEC filings (Ticker: SPNT), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
The SiriusPoint Ltd. (SPNT) SEC filings page on Stock Titan brings together the company’s U.S. regulatory disclosures, including current reports on Form 8-K and other key documents filed with the Securities and Exchange Commission. SiriusPoint is a Bermuda-incorporated global underwriter of insurance and reinsurance whose common shares and 8.00% Resettable Fixed Rate Preference Shares, Series B, are listed on the New York Stock Exchange under the symbols SPNT and SPNT PB. Its filings provide detailed insight into segment performance, capital structure, governance, and material corporate events.
Through its Form 8-K filings, SiriusPoint reports results of operations and financial condition, furnishing earnings press releases, financial supplements, and investor presentations for periods such as the second and third quarters. These documents explain Core results across the Insurance & Services and Reinsurance segments, combined ratios, underwriting income, Core net services income, and book value measures, as well as the impact of catastrophe losses and prior-year reserve development.
The company also uses Form 8-K to disclose material transactions and strategic actions, including the definitive agreement and subsequent completion of the sale of ArmadaCorp Capital, LLC, the holding company of supplemental health insurance program manager ArmadaCare, and the agreement to sell its equity stake in Arcadian Holdings Limited to an acquisition vehicle affiliated with Lee Equity Partners. Related exhibits often include press releases describing associated capacity agreements that extend underwriting authority for Arcadian through at least the end of 2031.
Additional filings cover governance and compensation matters, such as the adoption of the SiriusPoint Ltd. Executive Severance Plan, appointments and resignations of executive officers and directors, and determinations about director independence. SiriusPoint also files 8-Ks to announce quarterly cash dividends on its Series B preference shares, specifying dividend amounts, record dates, and payment dates.
On Stock Titan, these SEC filings are updated as they are released on EDGAR, and AI-powered summaries can help explain the significance of each report. Users can quickly see which filings relate to earnings (such as 10-Q and 10-K when available), which detail insider and executive changes, and which describe major transactions or capital actions, providing a structured view of SiriusPoint’s regulatory history.
SiriusPoint (SPNT) announced a leadership change in finance. The company disclosed that Chief Accounting Officer and principal accounting officer Evan Cabat will resign effective October 31, 2025 to pursue another opportunity. The company stated his departure is not due to any disagreement with the Board or management on financial statements, internal controls, operations, policies, or practices.
Until the effective date, Mr. Cabat will continue in his role and support the transition. Upon his departure, Chief Financial Officer Jim McKinney will also serve as the company’s principal accounting officer, in addition to his role as principal financial officer.
The Vanguard Group reported beneficial ownership of 11,757,727 shares of SiriusPoint Ltd common stock, representing 10.07% of the class as of the 09/30/2025 event date. Vanguard states it has sole dispositive power over 10,889,144 shares and shared voting power for 723,042 shares, reflecting portfolio management and client-directed holdings rather than an intent to influence control. The filing clarifies that Vanguard's clients have the right to receive dividends or proceeds and that no single outside person holds more than 5% of the class through Vanguard-managed accounts. The statement is certified by Vanguard's Head of Global Fund Administration on 10/06/2025.
SiriusPoint Ltd disclosed an amendment to its program management agreement with Arcadian and an extension of the underwriting term to December 31, 2031. The filing indicates the board did not vote to disapprove the action, allowing the company to execute the amendment. The notice references a related press release dated October 6, 2025 and is signed by Chief Legal Officer Linda S. Lin. The disclosure is brief and focuses on the contractual extension and administrative approval status rather than financial results.
SiriusPoint Ltd. announced that one of its subsidiaries entered into a definitive agreement to sell ArmadaCorp Capital, LLC, the holding company for its wholly owned supplemental health insurance program manager ArmadaCare, to a subsidiary of Ambac Financial Group Inc. for $250 million. The transaction’s closing is subject to customary closing conditions, including required regulatory approvals. The company also issued a press release describing the agreement, which is filed as an exhibit to this report.
Martin Hudson, a director of SiriusPoint Ltd. (SPNT), acquired 3,698 common shares on 09/09/2025 at a price of $18.59 per share. The purchase increases his beneficial ownership to 3,698 shares and includes restricted shares that vest in full on May 30, 2026, subject to his continued service as a director. The transaction was reported on a Form 4 and was signed by an attorney-in-fact on the reporting statement.
SiriusPoint Ltd. (SPNT) Form 3 reports that Martin Peter Hudson is identified as a director and the filing states that no securities are beneficially owned by the reporting person. The form notifies the issuer and investors that this individual has a director relationship but does not hold equity or derivative positions at the time of the statement.
SiriusPoint Ltd. reported that its board of directors appointed Martin Hudson as a Class III director, effective September 1, 2025. He will serve until the company’s 2028 annual general meeting of shareholders and until a successor is elected and qualified or an earlier departure.
Hudson, age 66, brings more than 40 years of international (re)insurance leadership experience, including roles as an independent non-executive director and chair across multiple insurance and reinsurance entities such as SiriusPoint International, Liberty Mutual entities, and Sirius International Managing Agency Ltd. The board concluded he should serve as a director based on his extensive industry and governance background.
The board determined that Hudson qualifies as an independent director under New York Stock Exchange and SEC rules. He will receive the same compensation as other non-employee directors and has entered into the company’s standard form of director indemnification agreement. The company stated there are no special arrangements, family relationships, or related-party transactions connected to his appointment. A press release announcing his appointment was issued on September 3, 2025 and filed as Exhibit 99.1.
Evan Cabat, identified as the Chief Accounting Officer of SiriusPoint Ltd. (SPNT), reported a change in his beneficial ownership of common shares following the vesting of restricted share units. The filing shows 588 shares were withheld to satisfy tax liabilities related to RSU vesting, recorded with transaction code F. After that withholding, Mr. Cabat beneficially owned 33,777 common shares, an amount the filer notes includes restricted shares. The disclosure was submitted via Form 4 and signed by an attorney-in-fact on behalf of Mr. Cabat.
Donald Smith & Co., Inc. and its DSCO Value Fund, L.P. report beneficial ownership of SiriusPoint Ltd common stock totaling 6,852,137 shares, representing 5.88% of the class. The filing shows Donald Smith & Co., Inc. holds the bulk of those shares with 6,593,154 shares of sole voting power and sole dispositive power, while DSCO Value Fund, L.P. holds 62,733 shares of sole voting and dispositive power. The reporting persons classify their holdings as held in the ordinary course of business and not for the purpose of influencing control.
This disclosure identifies the issuer as SiriusPoint Ltd and provides the issuer's principal executive office. The filing clarifies that no single advisory client of Donald Smith & Co., Inc. holds more than 5% of the class and states that various persons hold the remaining reported securities.
Capital Research Global Investors filed an amended Schedule 13G reporting beneficial ownership of 5,700,000 shares of SiriusPoint Ltd., representing 4.9% of the approximately 116.6 million shares outstanding. The filing is made under Rule 13d-1(b), indicating a passive disclosure for holdings under 5%. The filing states the shares are held in the ordinary course of business and were not acquired to change or influence control of the issuer. The disclosure clarifies voting and dispositive power are held solely by the reporting person.